Literature DB >> 2126104

Stomal recurrence after laryngectomy: interrelated risk factor study.

J Rubin1, J T Johnson, E N Myers.   

Abstract

This study was designed to identify pathogenic factors in recurrent carcinoma at the tracheal stoma. The charts of 444 patients with laryngeal cancer who were treated surgically between 1976 and 1988 revealed stomal recurrence in 15 (3.4%). Eighty percent of the patients with stomal recurrence had tumors in the subglottis. In comparison to patients with different sites involved this was significant (p less than 0.001). Other variables examined and analyzed included primary stage, previous treatment, neck pathologic status, neck treatment, age, sex, postoperative adjunctive therapy, and timing of tracheotomy. Tumor involvement of the subglottis is the single most important variable in stomal recurrence of carcinoma. Previous conservation laryngeal surgery and preoperative/emergency tracheotomy are not related to stomal recurrence of carcinoma. Mean length of survival for patients with stomal recurrence of carcinoma in our series was 8.9 months. Two patients were successfully treated with extensive surgical resection. The dismal prognosis of stomal recurrence of carcinoma suggests that management of this condition should focus on prevention. Treatment of patients with tumors of the subglottis should include attention to the paratracheal region and superior mediastinum, in conjunction with laryngectomy immediately after initial diagnosis.

Entities:  

Mesh:

Year:  1990        PMID: 2126104     DOI: 10.1177/019459989010300523

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  [Seeding metastases due to tracheotomy?].

Authors:  A Koitschev
Journal:  HNO       Date:  2007-02       Impact factor: 1.284

2.  Molecular characterization of late stomal recurrence following total laryngectomy.

Authors:  Josena K Stephen; Mausumi Symal; Kang Mei Chen; Tamer Ghanem; Robert Deeb; Veena Shah; Shaleta Havard; Maria J Worsham
Journal:  Oncol Rep       Date:  2011-01-10       Impact factor: 3.906

3.  [Reasons for the terms "radiosurgery" and "Gamma Knife"].

Authors:  K Hamm; G Surber
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

4.  Pre-operative tracheostomy does not impact on stomal recurrence and overall survival in patients undergoing primary laryngectomy.

Authors:  Thomas F Pezier; Iain J Nixon; Anil Joshi; Leo Pang; Teresa Guerrero-Urbano; Richard Oakley; Jean-Pierre Jeannon; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-09       Impact factor: 2.503

5.  Clinical and molecular prognostic factors in operable laryngeal cancer.

Authors:  Konstantinos Vlachtsis; Angelos Nikolaou; Konstantinos Markou; George Fountzilas; Ioannis Daniilidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-01       Impact factor: 2.503

6.  High-dose radiotherapy alone for patients with T4-stage laryngeal cancer.

Authors:  A Mucha-Małecka; K Składowski
Journal:  Strahlenther Onkol       Date:  2013-07-05       Impact factor: 3.621

7.  [Argon plasma coagulation (APC) for palliative treatment of tracheostomal recurrences].

Authors:  U Hauser; T K Hoffmann; H Balló; M Sarbia; H Bier
Journal:  HNO       Date:  2003-04-08       Impact factor: 1.284

8.  Clinicopathologic Findings and Treatment Outcome of Laryngectomized Patients with Laryngeal Cancer and Hypopharyngeal Cancer: An Experience in Thailand

Authors:  Noppadol Larbcharoensub; Duangkamon Wattanatranon; Juvady Leopairut; Suwimon Suntisuktana; Boonsam Roongpupaht; Chalermchai Chintrakarn; Jumroon Tungkeeratichai; Phurich Praneetvatakul; Thongchai Bhongmakapat; Wichit Cheewaruangroj; Supawadee Prakunhungsit
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

Review 9.  Which risk factors are associated with stomal recurrence after total laryngectomy for laryngeal cancer? A meta-analysis of the last 30 years.

Authors:  Jiwang Liang; Xiangyu Zhu; Wei Zeng; Tao Yu; Fengqin Fang; Yuejiao Zhao
Journal:  Braz J Otorhinolaryngol       Date:  2020-04-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.